Evidence map›Paper›PMID 42787651›Full record

ArticlemicroPublication biology2026

Workflow for Accurate Measurement of PDI Reductase Kinetics Using a Fluorescent Disulfide Substrate.

Nathan Ponzar, Nicola Pozzi

Abstract read
In one paragraph

Article in microPublication biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nathan PonzarBiochemistry and Molecular Biology, Saint Louis University, St Louis, MO, United States.
Nicola PozziBiochemistry and Molecular Biology, Saint Louis University, St Louis, MO, United States.

Funding

Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid SyndromeR01HL150146 · NHLBI · SAINT LOUIS UNIVERSITY · PI POZZI, NICOLA · 2020 to 2024
$2.0M
NHLBI NIH HHS R01 HL150146
6 · The paper itself

Abstract

Protein disulfide isomerase (PDI) is essential for oxidative protein folding, proteostasis, and redox regulation and has become a promising target for thromboinflammation, cancer, and neurodegenerative disorders. Fluorogenic disulfide substrates like Bodipy FL L-cystine (BDSS) are essential for mechanistic studies but have low affinity for PDI, necessitating high micromolar concentrations to measure Michaelis-Menten kinetics. These conditions can lead to optical artifacts, requiring development of correction methods to enable rigorous characterization of PDI inhibitors and allosteric modulators. Here, we present a simple workflow for correcting fluorescence quenching during BDSS reduction assays and provide an example of its utility with two allosteric modulators.

Identifiers

PMID42787651
PMCPMC13601980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.